Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
121-135 of 2112 results
ImmunoCellular signs sponsored research deal with University of Texas MD Anderson Cancer
ImmunoCellular Therapeutics has entered into a sponsored research agreement with Dr. Cassian Yee at the University of Texas MD Anderson Cancer Center.
Contract Research & Services > Contract Research > News
Beckman Coulter, IncellDx sign distribution deal for human papilloma virus research
Beckman Coulter Life Sciences and IncellDx have signed a distribution agreement which focuses exclusively on clinical researchers in mainland China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer.
Contract Research & Services > Contract Research > News
Hanmi inks license agreement with Janssen
By PBR Staff Writer
South Korea-based Hanmi Pharmaceutical has signed a license agreement with Janssen Pharmaceuticals to develop a new diabetes and obesity drug.
Contract Research & Services > Contract Research > News
Ignyta buys rights to taladegib oncology program from Eli Lilly
By PBR Staff Writer
Ignyta has secured an exclusive global license to Eli Lilly and Company's taladegib, an orally available small molecule hedgehog/smoothened antagonist under development to treat a range of cancers.
Contract Research & Services > Contract Research > News
CytomX, MD Anderson Cancer Center partner for probody-enabled CAR-NK cell therapies
CytomX Therapeutics has entered into a collaboration with the University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.
Contract Research & Services > Contract Research > News
Novo Nordisk, University of Washington start research collaboration
Novo Nordisk and University of Washington have started a collaboration to explore the role of the brain in regulating blood glucose and obesity.
Contract Research & Services > Contract Research > News
GSK and Merck start Phase I trial of GSK3174998 with Keytruda
By PBR Staff Writer
GlaxoSmithKline (GSK) and Merck are trialing a combination of two separate drugs as a potential cancer treatment.
Contract Research & Services > Contract Research > News
Boehringer Ingelheim, BioMed X extend COPD collaboration
By PBR Staff Writer
Boehringer Ingelheim and the BioMed X Innovation Center have extended their collaboration to discover novel therapeutic concepts for the treatment of psychiatric diseases.
Contract Research & Services > Contract Research > News
Ultragenyx, Arcturus sign messenger RNA therapeutics deal
By PBR Staff Writer
Ultragenyx Pharmaceutical has partnered with Arcturus Therapeutics to discover and develop messenger RNA (mRNA) therapeutics for rare disease targets.
Contract Research & Services > Contract Research > News
BioCision, UCSF partner to advance cell therapy for organ transplantation and diabetes
By PBR Staff Writer
BioCision has collaborated with the University of California, San Francisco (UCSF) to advance cell therapy for organ transplantation and diabetes.
Contract Research & Services > Contract Research > News
Arena Pharmaceuticals unveils plans to improve efficiencies and reduce costs
Arena Pharmaceuticals has unveiled plans to improve efficiencies and reduce costs as it focuses on the advancement of its research and development priorities.
Contract Research & Services > Contract Research > News
XBiotech starts research to develop antibody against Clostridium difficile
By PBR Staff Writer
XBiotech has launched a research and development (R&D) program to develop an oral monoclonal antibody against Clostridium difficile (C. difficile) infection.
Contract Research & Services > Contract Research > News
Ipsen and EpiVax partner to create next generation botulinum neurotoxin
By PBR Staff Writer
French pharmaceutical firm Ipsen and US biotechnology company EpiVax have completed a collaborative project that offers a novel approach to create next generation botulinum neurotoxin (BoNT) and targeted secretion inhibitor (TSI) therapeutics.
Contract Research & Services > Contract Research > News
US National Cancer Institute awards grant to Apogee for YELIVA prostate cancer research
The US National Cancer Institute (NCI) has awarded Apogee Biotechnology a $225,000 Small Business Innovation Research Program (SBIR) grant to support a pre-clinical study with YELIVA (ABC294640) for the treatment of prostate cancer.
Contract Research & Services > Contract Research > News
AstraZeneca and Eli Lilly expand immuno-oncology partnership to treat solid tumours
By PBR Staff Writer
AstraZeneca and Eli Lilly and Company have expanded their collaboration in cancer immunotherapy to test new drug combinations for treating solid tumours.
Contract Research & Services > Contract Research > News
121-135 of 2112 results